Chronic obstructive pulmonary disease in combination with cardiovascular diseases: treatment with inhalatory cholinolytic drugs1


Cite item

Full Text

References

  1. Reynolds R. J., Buford J. G., George R. B. Treating asthma and COPD in patients with heart disease. J. Respir. Dis. 1982; 3: 41.
  2. Behar S., Panosh A., Rekher-Reiss H. et al. Prevalence and prognosis of chronic obstructive pulmonary disease among 5,839 consecutive patients with acute myocardial infarction. SPRINT Study Group. Am. J. Med. 1992; 93: 637.
  3. Shih H. Т., Webb С. R., Conway W. A. et al. Frequency and significance of cardiac arrhythmias in chronic obstructive lung disease. Chest 1988; 94: 44.
  4. Jousilahti P., Vartiainen E., Tuomilehto J. et al. Symptoms of chronic bronchitis and the risk of coronary disease. Lancet 1996; 348: 567.
  5. Fuso L., Incalz R. A., Pistelli R. et al. Predicting mortality of patients hospitalized for acutely exacerbated chronic obstructive pulmonary disease. Am. J. Med. 1995; 98: 272.
  6. Козлова Л. И., Бузунов Р. В., Чучалин А. Г. Хроническая обструктивная болезнь легкого у больных с ишемической болезнью сердца: 15-летнее исследование. Тер. арх. 2001; 73 (3, прил. 10): 11-21.
  7. Summers R. J., Molnaar P., Russell F. et al. Coexistence and localization of beta 1- and beta 2-adrenoceptors in the human heart. Eur. Heart J. 1989; 10 (suppl. B): 11-21.
  8. Neville E., Corns P. A., Vivian J. et al. Nebulised salbutamol and angina. Br. Med. J. 1982; 285 (6344): 796-797.
  9. Au D. H., Curtis J. R., Every N. R. et al. Association between inhaled beta-agonists and the risk of unstable angina and myocardial infarction. Chest 2002: 12! (3): 846-851.
  10. Oga Т., Nishimura K., Tsukino M. et al. A comparison of the effects of salbutamol and ipratropium bromide on exercise endurance in patients with COPD. Chest 2003; 123 (6): 1810- 1816.
  11. Langley S. J., Towse L., Kesten S., Calverley P. M. Heart rate and rhythm analysis from holter monitoring in COPD patients receiving tiotropium. A. J. Respir. Crit. Care Med. 2002; 165 (8): A592.
  12. ZuWallack R., Morganroth J., Lanes S., Kesten S. Electrocardiographic evaluations in COPD patients treated with tiotropium in 1-year clinical trials. Am. J. Respir. Crit. Care Med. 2003; 167 (7): A94.
  13. O'Donnell D. E., Helgo Magnussen H., Gerken F. et al. Mechanisms of improved exercise tolerance in COPD in response to tiotropium. Eur. Respir. J. 2002; 19 (suppl.): P1826.
  14. O'Donnell D. E., Magnussen H., Gerken F. et al. Cardiovascular evaluation of tiotropium during constant work rate exercise in COPD. Eur. Respir. J. 2003; 22 (suppl. 45): 49s.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2004 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 

Address of the Editorial Office:

  • Novij Zykovskij proezd, 3, 40, Moscow, 125167

Correspondence address:

  • Alabyan Street, 13/1, Moscow, 127055, Russian Federation

Managing Editor:

  • Tel.: +7 (926) 905-41-26
  • E-mail: e.gorbacheva@ter-arkhiv.ru

 

 © 2018-2021 "Consilium Medicum" Publishing house


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies